MAX-DELBRUECK-CENTRUM FUER MOLEKULARE MEDIZIN
Patent Owner
Stats
- 33 US PATENTS IN FORCE
- 4 US APPLICATIONS PENDING
- Feb 22, 2018 most recent publication
Details
- 33 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 625 Total Citation Count
- Mar 31, 1994 Earliest Filing
- 61 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0044,233 REPERTOIRE OF ALLO-RESTRICTED PEPTIDE-SPECIFIC T CELL RECEPTOR SEQUENCES AND USE THEREOFJul 07, 16Feb 16, 17[C07K]
2015/0045,237 METHOD FOR IDENTIFICATION OF THE SEQUENCE OF POLY(A)+RNA THAT PHYSICALLY INTERACTS WITH PROTEINMar 18, 13Feb 12, 15[C12Q, C12N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9862953 Use of aptamers in therapy and/or diagnosis of autoimmune diseasesDec 22, 15Jan 09, 18[C07H, C12N, G01N, A61M]
9492495 Therapeutic use of agonists or antagonists of bradykinin receptor 1 or 2, for modulation collateral blood vessel growthMay 16, 11Nov 15, 16[A61K, C07K]
9409969 Repertoire of allo-restricted peptide-specific T cell receptor sequences and use thereofFeb 09, 10Aug 09, 16[C07H, C07K]
9238837 Biomarkers for determination of temporal phase of acute kidney injuryJun 17, 11Jan 19, 16[C12Q, G01N]
9234201 Use of aptamers in therapy and/or diagnosis of autoimmune diseasesMar 02, 12Jan 12, 16[A61K, C07H, C12Q, C12N, G01N, A61M]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0008,339 PSORALEN DERIVATIVES FOR PREVENTING OR TREATING HEART FAILURE OR CARDIAC HYPERTROPHYAbandonedJul 02, 13Jan 14, 16[A61K]
2014/0077,800 MAGNETIC FIELD APPARATUS AND METHOD OF OPERATING A MAGNETIC FIELD APPARATUSAbandonedFeb 25, 11Mar 20, 14[G01R]
2014/0031,309 Beta-L-N4 Hydroxycytosine Deoxynucleosides and their use as Pharmaceutical Agents in the Prophylaxis or Therapy of Viral DiseasesAbandonedJan 25, 13Jan 30, 14[C07H, A61K]
2014/0031,411 GPNMB/OSTEOACTIVIN AS A BIOMARKER AND DRUG TARGET IN CARDIAC DISEASESAbandonedDec 01, 11Jan 30, 14[C12Q, G01N]
8440609 Peptides against autoantibodies causing intolerance to cold and use thereofExpiredJan 29, 04May 14, 13[A61K]
2012/0276,539 USE OF METASTASIS PROGRESSOR S100A4 TRANSCRIPTS IN BODY FLUIDS OF COLORECTAL AND GASTRIC CANCER PATIENTSAbandonedMar 19, 10Nov 01, 12[C12Q]
2011/0189,141 MULTIPLE TARGET T CELL RECEPTORAbandonedMay 19, 10Aug 04, 11[A61K, C07H, C12P, C12N, A61P, C07K]
2011/0014,697 Method and Kit for Rapid Isolation of Human Foxp3+ Treg CellsAbandonedOct 10, 08Jan 20, 11[C12N]
2009/0220,469 PEPTIDES AGAINST AUTOANTIBODIES ASSOCIATED WITH GLAUCOMA AND USE OF THESE PEPTIDESAbandonedMar 09, 07Sep 03, 09[A61K, C07H, C12Q, C12N, C07K, B01D]
7534425 Animal model and cell-line expressing modified chlorine channelExpiredJul 18, 03May 19, 09[A61K, A01N, C12N]
2009/0105,186 Beta-L-N4-Hydroxycytosine Deoxynucleosides and their use as Pharmaceutical Agents in the Prophylaxis or Therapy of Viral DiseasesAbandonedOct 21, 05Apr 23, 09[A61K, C07H, A61P]
2009/0023,662 Identification of Agonistic Autoantibodies Associated with Humoral Kidney RejectionAbandonedNov 30, 07Jan 22, 09[A61K, G01N, A61P]
2009/0004,212 Tumour vaccines for MUC1-positive carcinomasAbandonedJan 14, 08Jan 01, 09[A61K, C12P, C12N, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.